Dearborn Partners Portfolio holdings
Dearborn Partners builds portfolios of companies it expects to keep raising their dividends, an approach it calls its Rising Dividend strategy. Three Chicago investment managers who wanted to offer more personal service joined together to form the firm in 1997. Carol Lippman, who began formulating the Rising Dividend approach in 1993 at another firm, joined in 2011 and manages the strategy, with Michael Andelman as co-portfolio manager. Dearborn also advises the Dearborn Partners Rising Dividend Fund, a mutual fund, and serves financial advisors, high net worth families and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prosperity Bancshares
PB
|
+$18.6M |
| 2 |
Watsco
WSO
|
+$17.8M |
| 3 |
Nasdaq
NDAQ
|
+$12.3M |
| 4 |
Walgreens Boots Alliance
WBA
|
+$4.34M |
| 5 |
ExxonMobil
XOM
|
+$3.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$18.1M |
| 2 |
Fortis
FTS
|
+$16.4M |
| 3 |
Starbucks
SBUX
|
+$15.2M |
| 4 |
Broadridge
BR
|
+$10.7M |
| 5 |
Steris
STE
|
+$5.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.87% |
| 2 | Technology | 16.61% |
| 3 | Healthcare | 14.37% |
| 4 | Financials | 12.62% |
| 5 | Consumer Discretionary | 9.1% |
Similar funds
Dearborn Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Dearborn Partners held 184 positions worth $1.28B, down 1.3% from $1.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Dearborn Partners withdrew a net $48.4M in Q2 2018, closing 10 positions and reducing 94 holdings. Its most notable exit was Fortis, an estimated $16.4M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Dearborn Partners opened a new position in Prosperity Bancshares worth $17.4M.
- Dearborn Partners's largest Q2 2018 buy was Prosperity Bancshares: 255,080 shares worth $17.4M.
- Dearborn Partners added most to Watsco in Q2 2018, an estimated $17.8M increase.
- Dearborn Partners's biggest Q2 2018 reduction was Novartis, cutting an estimated $18.1M.
- Dearborn Partners fully exited Fortis in Q2 2018, selling an estimated $16.4M.
- Dearborn Partners's ten largest holdings make up 26% of its $1.28B portfolio in Q2 2018.
- Dearborn Partners opened 12 new positions and closed 10 in Q2 2018.
- Dearborn Partners's portfolio value fell 1.3% quarter-over-quarter to $1.28B.
Based on Dearborn Partners's 13F filing for Q2 2018, filed 14 Aug 2018.